Food and Drug Administration (FDA) approval in May 2022 for type 2 diabetes, November 2023 for chronic weight management, and December 2024 for obstructive sleep apnea, marking it as the first approved therapy for this indication
Hemp cultivation is already legal in Canada and the EU
Nutrient Levels to Consider During GLP-1 Weight Loss Significant appetite reduction and rapid weight loss can affect nutrient intake over time
Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: A double-blind, randomized, placebo-controlled clinical trial
There is limited information on the drugs long-term safety
Most people experience some version of the following: Acute symptoms (headaches, sinus issues, sleep disruption) may temporarily worsen for the first few days as exposure ends and the body begins releasing stored toxins (Herxheimer reaction) By the end of week two, the worst acute symptoms typically begin to ease Sleep often starts improving first a useful early signal Energy is usually still low
